FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Christophe Louvet

Research Profile

Procedures

Chemicals & Drugs

Disorders

Concepts & Ideas

Co-author Network

Publications

TOP 3
Frédéric Bibeau; Christophe Louvet; Emmanuel Mitry; Pauline Afchain; Pascal Artru; Thierry André
[Observational study on conditions for access to the analysis of KRAS mutation in patients with metastatic colorectal cancer receiving panitumumab treatment].
Francois-Clement Bidard; V Boige; A de Gramont; M Ducreux; F R Ferrand; P Hammel; F Huguet; Christophe Louvet; D Malka; P Mariani; T Andre; Jean-Yves Pierga
Disseminated and circulating tumor cells in gastrointestinal oncology.
Benoist Chibaudel; Thierry André; Pascal Artru; Leila Bengrine-Lefevre; Franck bonnetain; Jérôme Desramé; Annette K Larsen; Christophe Louvet; Luis Teixeira; Christophe Tournigand; Aimery de Gramont
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Christophe Louvet (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Frédéric Bibeau; Christophe Louvet; Emmanuel Mitry; Pauline Afchain; Pascal Artru; Thierry André
[Observational study on conditions for access to the analysis of KRAS mutation in patients with metastatic colorectal cancer receiving panitumumab treatment].
Bulletin du cancer 2012;99(7-8):743-51.
2012: Francois-Clement Bidard; V Boige; A de Gramont; M Ducreux; F R Ferrand; P Hammel; F Huguet; Christophe Louvet; D Malka; P Mariani; T Andre; Jean-Yves Pierga
Disseminated and circulating tumor cells in gastrointestinal oncology.
Critical reviews in oncology/hematology 2012;82(2):103-15.
2011: Benoist Chibaudel; Thierry André; Pascal Artru; Leila Bengrine-Lefevre; Franck bonnetain; Jérôme Desramé; Annette K Larsen; Christophe Louvet; Luis Teixeira; Christophe Tournigand; Aimery de Gramont
Simplified prognostic model in patients with oxaliplatin-based or irinotecan-based first-line chemotherapy for metastatic colorectal cancer: a GERCOR study.
The oncologist 2011;16(9):1228-38.
2010: Isabelle Baumgaertner; Emmanuel Quinaux; Ahmed Khalil; Christophe Louvet; Marc Buyse; Aimery de Gramont; Thierry André
Comparison of the levogyre and dextro-levogyre forms of leucovorin in a phase III trial of bimonthly LV5FU2 versus monthly 5-fluorouracil and high-dose leucovorin for patients with stage II and III colon cancer (GERCOR C96.1).
Clinical colorectal cancer 2010;9(2):E5-10.
2010: Christophe Louvet; Thierry André; E Gamelin; M Hebbar; May Mabro; M Bennamoun; H Rassam; A de Gramont
Phase II Study of Biweekly Pemetrexed Plus Irinotecan as Second-Line Therapy for Metastatic Colorectal Cancer.
Journal of oncology 2010;2010():785934.
2009: Benoist Chibaudel; Frédérique Maindrault-Goebel; Gérard Lledo; Laurent Mineur; Thierry André; Mostepha Bennamoun; May Mabro; Pascal Artru; Elisabeth Carola; Michel Flesch; Olivier Dupuis; Philippe Colin; Annette K Larsen; Pauline Afchain; Christophe Tournigand; Christophe Louvet; Aimery de Gramont
Can chemotherapy be discontinued in unresectable metastatic colorectal cancer? The GERCOR OPTIMOX2 Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(34):5727-33.
2008: Thierry André; J M Reyes-Vidal; L Fartoux; P Ross; M Leslie; Olivier Rosmorduc; M R Clemens; Christophe Louvet; N Perez; F Mehmud; W Scheithauer
Gemcitabine and oxaliplatin in advanced biliary tract carcinoma: a phase II study.
British journal of cancer 2008;99(6):862-7.
2008: Christophe Louvet; Philip A Philip
Accomplishments in 2007 in the treatment of metastatic pancreatic cancer.
Gastrointestinal cancer research : GCR 2008;2(3 Suppl):S37-41.
2008: Laurence Moureau-Zabotto; Jean-Marc Phélip; Pauline Afchain; Laurent Mineur; Thierry André; Veronique Vendrely; Gérard Lledo; Olivier Dupuis; Florence Huguet; Emmanuel Touboul; Jacques Balosso; Christophe Louvet
Concomitant administration of weekly oxaliplatin, fluorouracil continuous infusion, and radiotherapy after 2 months of gemcitabine and oxaliplatin induction in patients with locally advanced pancreatic cancer: a Groupe Coordinateur Multidisciplinaire en Oncologie phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(7):1080-5.
2008: Astrid Lièvre; Jean-Baptiste Bachet; Valérie Boige; Anne Cayre; Delphine Le Corre; Emmanuel Buc; Marc Ychou; Olivier Bouché; Bruno Landi; Christophe Louvet; Thierry André; Frédéric Bibeau; Marie-Danièle Diebold; Philippe Rougier; Michel Ducreux; Gorana Tomasic; Jean-François Emile; Frédérique Penault-Llorca; Pierre Laurent-Puig
KRAS mutations as an independent prognostic factor in patients with advanced colorectal cancer treated with cetuximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(3):374-9.
2008: Volker Heinemann; Stefan Boeck; Axel Hinke; Roberto Labianca; Christophe Louvet
Meta-analysis of randomized trials: evaluation of benefit from gemcitabine-based combination chemotherapy applied in advanced pancreatic cancer.
BMC cancer 2008;8():82.
2007: Arie Figer; Nathalie Perez-Staub; Elisabeth Carola; Christophe Tournigand; Gerard Lledo; Michel Flesch; Ramon Barcelo; Andre Cervantes; Thierry André; Philippe Colin; Christophe Louvet; Aimery de Gramont
FOLFOX in patients aged between 76 and 80 years with metastatic colorectal cancer: an exploratory cohort of the OPTIMOX1 study.
Cancer 2007;110(12):2666-71.
2007: Jean-Baptiste Bachet; Pauline Afchain; Christophe Fermanian; Mohamed Bouchahda; Emmanuel Mitry; Bruno Landi; Thierry André; Astrid Lièvre; Christophe Louvet; Philippe AEGERTER; Francis Levi; Philippe Rougier
Cetuximab efficacy in patients treated routinely in university hospitals.
Gastroentérologie clinique et biologique 2007;31(11):941-9.
2007: Stéphanie Träger-Maury; Christophe Tournigand; Frédérique Maindrault-Goebel; Pauline Afchain; Aimery de Gramont; Marie-Line Garcia-Larnicol; Honorine Gervais; Christophe Louvet
[Use of complementary medicine by cancer patients in a French oncology department].
Bulletin du cancer 2007;94(11):1017-25.
2007: Thierry André; Emmanuel Quinaux; Christophe Louvet; Philippe Colin; Erick Gamelin; Olivier Bouche; Emmanuel Achille; Pascal Piedbois; Nicole Tubiana-Mathieu; Arnaud Boutan-Laroze; Michel Flesch; Gérard Lledo; Yves Raoul; Isabelle Debrix; Marc Buyse; Aimery de Gramont
Phase III study comparing a semimonthly with a monthly regimen of fluorouracil and leucovorin as adjuvant treatment for stage II and III colon cancer patients: final results of GERCOR C96.1.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(24):3732-8.
2007: Aimery de Gramont; Marc Buyse; Jose Cortinas Abrahantes; Tomasz Burzykowski; Emmanuel Quinaux; Andrés Cervantes; Arie Figer; Gérard Lledo; Michel Flesch; Laurent Mineur; Elisabeth Carola; Pierre-Luc Etienne; Fernando Rivera; Isabel Chirivella; Nathalie Perez-Staub; Christophe Louvet; Thierry André; Isabelle Tabah-Fisch; Christophe Tournigand
Reintroduction of oxaliplatin is associated with improved survival in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(22):3224-9.
2007: Thierry André; Pauline Afchain; Alain Barrier; Pierre Blanchard; Annette K Larsen; Christophe Tournigand; Christophe Louvet; Aimery de Gramont
Current status of adjuvant therapy for colon cancer.
Gastrointestinal cancer research : GCR 2007;1(3):90-7.
2007: Aimery de Gramont; Christophe Tournigand; Thierry André; Annette K Larsen; Christophe Louvet
Adjuvant therapy for stage II and III colorectal cancer.
Seminars in oncology 2007;34(2 Suppl 1):S37-40.
2007: Florence Huguet; Thierry André; Pascal Hammel; Pascal Artru; Jacques Balosso; Frédéric Selle; Elisabeth Deniaud-Alexandre; Philippe Ruszniewski; Emmanuel Touboul; Roberto Labianca; Aimery de Gramont; Christophe Louvet
Impact of chemoradiotherapy after disease control with chemotherapy in locally advanced pancreatic adenocarcinoma in GERCOR phase II and III studies.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(3):326-31.
2007: Aimery de Gramont; Annette K Larsen; Christophe Tournigand; Christophe Louvet; Thierry André
Update on targeted agents for adjuvant treatment of colon cancer in 2006.
Gastrointestinal cancer research : GCR 2007;1(4 Suppl 2):S47-9.
2007: Thierry André; Christophe Tournigand; Laurent Mineur; R Fellague-Chebra; Michel Flesch; May Mabro; Mohamed Hebbar; S Postel Vinay; Francois-Clement Bidard; Christophe Louvet; Aimery de Gramont
Phase II study of an optimized 5-fluorouracil-oxaliplatin strategy (OPTIMOX2) with celecoxib in metastatic colorectal cancer: a GERCOR study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2007;18(1):77-81.
2007: Pierre Blanchard; Anne Plantade; Cécile Pagès; Pauline Afchain; Christophe Louvet; Christophe Tournigand; Aimery de Gramont
Isolated lymph node relapse of epithelial ovarian carcinoma: outcomes and prognostic factors.
Gynecologic oncology 2007;104(1):41-5.
2006: Aimery de Gramont; Christophe Tournigand; Thierry André; Annette K Larsen; Christophe Louvet
Targeted agents for adjuvant therapy of colon cancer.
Seminars in oncology 2006;33(6 Suppl 11):S42-5.
2006: May Mabro; Pascal Artru; Thierry André; Michel Flesch; Frédérique Maindrault-Goebel; Bruno Landi; Gérard Lledo; Anne Plantade; Christophe Louvet; Aimery de Gramont
A phase II study of FOLFIRI-3 (double infusion of irinotecan combined with LV5FU) after FOLFOX in advanced colorectal cancer patients.
British journal of cancer 2006;94(9):1287-92.
2006: Mohamed Hebbar; Christophe Tournigand; Gérard Lledo; May Mabro; Thierry André; Christophe Louvet; Thomas Aparicio; Michel Flesch; Charles Varette; Aimery de Gramont
Phase II trial alternating FOLFOX-6 and FOLFIRI regimens in second-line therapy of patients with metastatic colorectal cancer (FIREFOX study).
Cancer investigation 2006;24(2):154-9.
2006: Christophe Tournigand; Andrés Cervantes; Arie Figer; Gérard Lledo; Michel Flesch; Marc Buyse; Laurent Mineur; Elisabeth Carola; Pierre-Luc Etienne; Fernando Rivera; Isabel Chirivella; Nathalie Perez-Staub; Christophe Louvet; Thierry André; Isabelle Tabah-Fisch; Aimery de Gramont
OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer--a GERCOR study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(3):394-400.
2006: Suzanne Nguyen; Christine Rebischung; Johan Van Ongeval; Michel Flesch; Mustapha Bennamoun; Thierry André; Marc Ychou; Erik Gamelin; Elisabeth Carola; Christophe Louvet
Epirubicin-docetaxel in advanced gastric cancer: two phase II studies as second and first line treatment.
Bulletin du cancer 2006;93(1):E1-6.
2005: Frédérique Maindrault-Goebel; Thierry André; Christophe Tournigand; Christophe Louvet; Nathalie Perez-Staub; Nora Zeghib; Aimery de Gramont
Allergic-type reactions to oxaliplatin: retrospective analysis of 42 patients.
European journal of cancer (Oxford, England : 1990) 2005;41(15):2262-7.
2005: Anne-Marie Coudray; Christophe Louvet; Michel Kornprobst; Eric Raymond; Thierry André; Christophe Tournigand; Sandrine Faivre; Aimery de Gramont; Annette K Larsen; Christian Gespach
Increased anticancer activity of the thymidylate synthase inhibitor BGC9331 combined with the topoisomerase I inhibitor SN-38 in human colorectal and breast cancer cells: induction of apoptosis and ROCK cleavage through caspase-3-dependent and -independent mechanisms.
International journal of oncology 2005;27(2):553-61.
2005: Christophe Louvet; Roberto Labianca; P Hammel; Gérard Lledo; Maria Giulia Zampino; Thierry André; alberto zaniboni; M Ducreux; E Aitini; Julien Taïeb; R Faroux; C Lepere; Aimery de Gramont
Gemcitabine in combination with oxaliplatin compared with gemcitabine alone in locally advanced or metastatic pancreatic cancer: results of a GERCOR and GISCAD phase III trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(15):3509-16.
2005: Aimery de Gramont; Christophe Tournigand; Christophe Louvet; Frédérique Maindrault-Goebel; Thierry André
First-line therapy for advanced colorectal cancer.
Current oncology reports 2005;7(3):167-72.
2005: Julien Taïeb; Pascal Artru; François Paye; Christophe Louvet; Nathalie Perez; Thierry André; Brice Gayet; Mohamed Hebbar; Frédérique Maindrault Goebel; Christophe Tournigand; Rolland Parc; Aimery de Gramont
Intensive systemic chemotherapy combined with surgery for metastatic colorectal cancer: results of a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(3):502-9.
2004: Christophe Louvet; Thierry André; Erick Gamelin; M-L Garcia; A Saavedra; G Lenaers; Aimery de Gramont; Dominique Méry-Mignard; S Kalla
A phase I-II, dose-escalating trial of ZD9331 in combination with irinotecan (CPT11) in previously pretreated metastatic colorectal cancer patients.
Bulletin du cancer 2004;91(12):279-84.
2004: Thierry Conroy; Guillaume Gory-Delabaere; Antoine Adenis; Lise Bosquet; Olivier Bouché; Christophe Louvet; Emmanuel Mitry; Yves Bécouarn; Jean-François Bosset; Michel Ducreux; Pierre-Luc Etienne; Yacine Merrouche; Geneviève Monges; Philippe Rougier
[Clinical practice guideline: 2003 update of Standards, Options et Recommendations for first line palliative chemotherapy in patients with metastatic colorectal cancer (summary report)].
Bulletin du cancer 2004;91(10):759-68.
2004: Thierry André; Christophe Tournigand; Olivier Rosmorduc; S Provent; Frédérique Maindrault-Goebel; D Avenin; Frédéric Selle; François Paye; L Hannoun; Sidney Houry; B Gayet; Jean-Pierre Lotz; Aimery de Gramont; Christophe Louvet
Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(9):1339-43.
2004: Thierry André; Monique Noirclerc; Pascal Hammel; Roderich Meckenstock; Bruno Landi; Stéphane Cattan; Frédéric Selle; Jean-François Codoul; Béatrice Guerrier-Parmentier; Rabia Mokhtar; Christophe Louvet
Phase II study of leucovorin, 5-fluorouracil and gemcitabine for locally advanced and metastatic pancreatic cancer (FOLFUGEM 2).
Gastroentérologie clinique et biologique 2004;28(8-9):645-50.
2004: Frédérique Maindrault-Goebel; Christophe Tournigand; Thierry André; Elisabeth Carola; May Mabro; Pascal Artru; Christophe Louvet; Aimery de Gramont
Oxaliplatin reintroduction in patients previously treated with leucovorin, fluorouracil and oxaliplatin for metastatic colorectal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1210-4.
2004: Christophe Louvet
[Indications and methods for adjuvant chemotherapy of colonic cancer].
Pathologie-biologie 2004;52(3):119-22.
2004: N Perez; Christophe Tournigand; May Mabro; Jean-Luc Molitor; Pascal Artru; Elisabeth Carola; Thierry André; Christophe Louvet; Marcel Krulik; Aimery de Gramont
[Long term survival in metastatic colorectal cancer treated with leucovorin and 5-fluoro-uracil chemotherapy].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 2004;25(2):124-8.
2004: Christophe Tournigand; Thierry André; Emmanuel Achille; Gérard Lledo; Michel Flesh; Dominique Mery-Mignard; Emmanuel Quinaux; Corinne Couteau; Marc Buyse; Gérard Ganem; Bruno Landi; Philippe Colin; Christophe Louvet; Aimery de Gramont
FOLFIRI followed by FOLFOX6 or the reverse sequence in advanced colorectal cancer: a randomized GERCOR study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(2):229-37.
2004: Thierry André; Christophe Louvet; Aimery de Gramont
[Colon cancer: what is new in 2004?].
Bulletin du cancer 2004;91(1):75-80.
2003: Christophe Tournigand; Christophe Louvet; Jean-Luc Molitor; Xavier Fritel; Nidal Dehni; Alain Sezeur; Alain Pigné; Jean Cady; Jacques Milliez; Aimery de Gramont
Long-term survival with consolidation intraperitoneal chemotherapy for patients with advanced ovarian cancer with pathological complete remission.
Gynecologic oncology 2003;91(2):341-5.
2003: Thierry Andre; Philippe Colin; Christophe Louvet; Erick Gamelin; Olivier Bouche; Emmanuel Achille; Nicolas Colbert; Catherine Boaziz; Pascal Piedbois; Nicole Tubiana-Mathieu; Arnaud Boutan-Laroze; Michel Flesch; Marc Buyse; Aimery de Gramont
Semimonthly versus monthly regimen of fluorouracil and leucovorin administered for 24 or 36 weeks as adjuvant therapy in stage II and III colon cancer: results of a randomized trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(15):2896-903.
2003: May Mabro; Christophe Louvet; Thierry André; Elisabeth Carola; Véronique Gilles-Amar; Pascal Artru; Marcel Krulik; Aimery de Gramont
Bimonthly leucovorin, infusion 5-fluorouracil, hydroxyurea, and irinotecan (FOLFIRI-2) for pretreated metastatic colorectal cancer.
American journal of clinical oncology 2003;26(3):254-8.
2003: Pierre Nahon; Pascal Artru; Christophe Tournigand; Christophe Louvet; Marcel Krulik; Aimery de Gramont
[Renal metastasis after curative resection of an epidermoid carcinoma of the esophagus].
Gastroentérologie clinique et biologique 2003;27(5):555-6.
2003: Christophe Louvet; Fabrice CARRAT; Frédéric Mal; May Mabro; Karine Beerblock; Jean-Christophe Vaillant; Jean Cady; Thierry André; Erick Gamelin; Aimery de Gramont
Prognostic factor analysis in advanced gastric cancer patients treated with hydroxyurea, leucovorin, 5-fluorouracil, and cisplatin (HLFP regimen).
Cancer investigation 2003;21(1):14-20.
2002: Christophe Louvet; Thierry André; Jean-Marie Tigaud; Erick Gamelin; Jean-Yves Douillard; R Brunet; Eric François; Jacques-Henri Jacob; D Levoir; Abdelkrim Taamma; Philippe Rougier; Esteban Cvitkovic; Aimery de Gramont
Phase II study of oxaliplatin, fluorouracil, and folinic acid in locally advanced or metastatic gastric cancer patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(23):4543-8.
2002: Samir Attoub; Christine Rivat; Sylvie Rodrigues; Saskia Van Bocxlaer; Monique Bedin; Erik Bruyneel; Christophe Louvet; Michel Kornprobst; Thierry André; Marc Mareel; Jan Mester; Christian Gespach
The c-kit tyrosine kinase inhibitor STI571 for colorectal cancer therapy.
Cancer research 2002;62(17):4879-83.
2002: Christophe Louvet; Thierry André; Pascal Artru
[Gemcitabine-based combinations in inoperable pancreatic cancers].
Bulletin du cancer 2002;89 Spec No():S96-101.
2002: Eric Raymond; Christophe Louvet; Christophe Tournigand; Anne-Marie Coudray; Sandrine Faivre; Aimery de Gramont; Christian Gespach
Pemetrexed disodium combined with oxaliplatin, SN38, or 5-fluorouracil, based on the quantitation of drug interactions in human HT29 colon cancer cells.
International journal of oncology 2002;21(2):361-7.
2002: Christophe Louvet; Thierry André; Gérard Lledo; P Hammel; H Bleiberg; C Bouleuc; Erick Gamelin; Michel Flesch; E Cvitkovic; Aimery de Gramont
Gemcitabine combined with oxaliplatin in advanced pancreatic adenocarcinoma: final results of a GERCOR multicenter phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(6):1512-8.
2002: Julien Taïeb; Pascal Artru; B Baujat; May Mabro; Elisabeth Carola; F Maindrault; Christophe Tournigand; Marcel Krulik; Christophe Louvet; Aimery de Gramont
Optimisation of 5-fluorouracil (5-FU)/cisplatin combination chemotherapy with a new schedule of hydroxyurea, leucovorin, 5-FU and cisplatin (HLFP regimen) for metastatic oesophageal cancer.
European journal of cancer (Oxford, England : 1990) 2002;38(5):661-6.
2001: Christophe Tournigand; Christophe Louvet; Jean-Luc Molitor; Nidal Dehni; Véronique Lejeune; Alain Sezeur; A Pigne; L Marpeau; Jean Cady; Aimery de Gramont
Intravenous chemotherapy, early debulking surgery, and consolidation intraperitoneal chemotherapy in advanced ovarian carcinoma.
Gynecologic oncology 2001;83(2):198-204.
2001: Eric Raymond; Sandrine Faivre; Anne-Marie Coudray; Christophe Louvet; Christian Gespach
[Preclinical studies of oxaliplatin in combination chemotherapy].
Bulletin du cancer 2001;88 Spec No():S26-34.
2001: Thierry André; Christophe Louvet; Frédérique Maindrault-Goebel; A D Gramont
[Oxaliplatin in combination with 5-fluoro-uracil and folinic acid as treatment of metastatic colorectal cancer].
Bulletin du cancer 2001;88 Spec No():S20-5.
2001: Christophe Louvet; Aimery de Gramont; Christophe Tournigand; Pascal Artru; Frédérique Maindrault-Goebel; Marcel Krulik
Correlation between progression free survival and response rate in patients with metastatic colorectal carcinoma.
Cancer 2001;91(11):2033-8.
2001: Christophe Louvet; Thierry André; Pascal Hammel; Frédéric Selle; B Landi; S Cattan; M Fonck; M Flesch; P Colin; Jacques Balosso; Philippe Ruszniewski; Aimery de Gramont
Phase II trial of bimonthly leucovorin, 5-fluorouracil and gemcitabine for advanced pancreatic adenocarcinoma (FOLFUGEM).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(5):675-9.
2001: Frédérique Maindrault-Goebel; Aimery de Gramont; Christophe Louvet; Thierry André; Elisabeth Carola; May Mabro; Pascal Artru; V Gilles; Jean-Pierre Lotz; Victor Izrael; Marcel Krulik
High-dose intensity oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX 7).
European journal of cancer (Oxford, England : 1990) 2001;37(8):1000-5.
2001: Christophe Louvet
[New chemotherapies for colorectal cancer treatment].
Gastroentérologie clinique et biologique 2001;25(4 Suppl):B51-6.
2001: L Vedrine; Pascal Artru; Christophe Tournigand; Christophe Louvet; Aimery de Gramont; Marcel Krulik
[Meningeal carcinomatosis in gastric cancer].
Gastroentérologie clinique et biologique 2001;25(4):422-4.
2001: Pascal Artru; Christophe Tournigand; May Mabro; E Lucchi; Christophe Louvet; Aimery de Gramont; Marcel Krulik
[Primary hyperparathyroidism associated with colon cancer].
Gastroentérologie clinique et biologique 2001;25(2):208-9.
2001: Thierry André; Philippe Colin; Christophe Louvet; Erick Gamelin; Olivier Bouche; Emmanuel Achille; N Colbert; Catherine Boaziz; Pascal Piedbois; Nicole Tubiana-Mathieu; Arnaud Boutan-Laroze; Michel Flesch; V Billiau; Marc Buyse; A Gramont
Randomized adjuvant study comparing two schemes of 5-fluorouracil and leucovorin in stage B2 and C colon adenocarcinoma: study design and preliminary safety results. Groupe d'Etude et de Recherche Clinique en Oncologie Radiotherapies.
Seminars in oncology 2001;28(1 Suppl 1):35-40.
2000: Frédérique Maindrault-Goebel; Aimery de Gramont; Christophe Louvet; Thierry André; Elisabeth Carola; V Gilles; Jean-Pierre Lotz; Christophe Tournigand; May Mabro; Jean-Luc Molitor; Pascal Artru; Victor Izrael; Marcel Krulik
Evaluation of oxaliplatin dose intensity in bimonthly leucovorin and 48-hour 5-fluorouracil continuous infusion regimens (FOLFOX) in pretreated metastatic colorectal cancer. Oncology Multidisciplinary Research Group (GERCOR).
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2000;11(11):1477-83.
2000: Christophe Louvet; Anne-Marie Coudray; Christophe Tournigand; S Prévost; Eric Raymond; Aimery de Gramont; M Chazard; Christian Gespach
Synergistic antitumoral activity of combined UFT, folinic acid and oxaliplatin against human colorectal HT29 cell xenografts in athymic nude mice.
Anti-cancer drugs 2000;11(7):579-82.
2000: Aimery de Gramont; Arie Figer; Matthew T Seymour; M Homerin; A Hmissi; Jim Cassidy; C Boni; H Cortes-Funes; Andrés Cervantes; G Freyer; D Papamichael; N Le Bail; Christophe Louvet; D Hendler; F de Braud; C Wilson; François Morvan; A Bonetti
Leucovorin and fluorouracil with or without oxaliplatin as first-line treatment in advanced colorectal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(16):2938-47.
1999: Thierry André; M A Bensmaine; Christophe Louvet; Eric François; V Lucas; Françoise Desseigne; Karine Beerblock; Olivier Bouché; Elisabeth Carola; Yacine Merrouche; François Morvan; G Dupont-André; Aimery de Gramont
Multicenter phase II study of bimonthly high-dose leucovorin, fluorouracil infusion, and oxaliplatin for metastatic colorectal cancer resistant to the same leucovorin and fluorouracil regimen.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(11):3560-8.
1999: May Mabro; Véronique Gilles-Amar; Christophe Louvet; Elisabeth Carola; Frédérique Maindrault-Goebel; Aimery de Gramont; Marcel Krulik
[Bimonthly 5-fluorouracil in elderly patients with metastatic colorectal cancer. Study of 50 patients].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1999;20(10):863-8.
1999: Thierry André; Christophe Louvet; Frédérique Maindrault-Goebel; Corinne Couteau; May Mabro; Jean-Pierre Lotz; Véronique Gilles-Amar; Marcel Krulik; Elisabeth Carola; Victor Izrael; Aimery de Gramont
CPT-11 (irinotecan) addition to bimonthly, high-dose leucovorin and bolus and continuous-infusion 5-fluorouracil (FOLFIRI) for pretreated metastatic colorectal cancer. GERCOR.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1343-7.
1999: Frédérique Maindrault-Goebel; Christophe Louvet; Thierry André; Elisabeth Carola; Jean-Pierre Lotz; Jean-Luc Molitor; M L Garcia; Véronique Gilles-Amar; Victor Izrael; Marcel Krulik; Aimery de Gramont
Oxaliplatin added to the simplified bimonthly leucovorin and 5-fluorouracil regimen as second-line therapy for metastatic colorectal cancer (FOLFOX6). GERCOR.
European journal of cancer (Oxford, England : 1990) 1999;35(9):1338-42.
1998: Thierry André; Eric Chastre; Larissa Kotelevets; JC Vaillant; Christophe Louvet; Jacques Balosso; E Le Gall; Sophie Prévot; Christian Gespach
[Tumoral angiogenesis: physiopathology, prognostic value and therapeutic perspectives].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1998;19(12):904-13.
1998: Thierry André; Christophe Louvet; E Raymond; Christophe Tournigand; Aimery de Gramont
Bimonthly high-dose leucovorin, 5-fluorouracil infusion and oxaliplatin (FOLFOX3) for metastatic colorectal cancer resistant to the same leucovorin and 5-fluorouracil regimen.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1998;9(11):1251-3.
1998: Christophe Tournigand; Frédérique Maindrault-Goebel; Christophe Louvet; Aimery de Gramont; Marcel Krulik
Severe anaphylactic reactions to oxaliplatin.
European journal of cancer (Oxford, England : 1990) 1998;34(8):1297-8.
1998: Aimery de Gramont; Christophe Louvet; Thierry André; Christophe Tournigand; Marcel Krulik
A review of GERCOD trials of bimonthly leucovorin plus 5-fluorouracil 48-h continuous infusion in advanced colorectal cancer: evolution of a regimen. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
European journal of cancer (Oxford, England : 1990) 1998;34(5):619-26.
1998: Michel Ducreux; Christophe Louvet; M Bekradda; Esteban Cvitkovic
Oxaliplatin for the treatment of advanced colorectal cancer: future directions.
Seminars in oncology 1998;25(2 Suppl 5):47-53.
1998: Thierry André; Jacques Balosso; Christophe Louvet; Sidney Houry; JC Vaillant; Emmanuel Touboul; Jean-Pierre Lotz; Aimery de Gramont; Victor Izrael
[Adenocarcinoma of the pancreas. Therapeutic strategies].
Presse médicale (Paris, France : 1983) 1998;27(11):539-45.
1998: Thierry André; Jacques Balosso; Christophe Louvet; Joseph GLIGOROV; Corinne Couteau; D Avenin; Aimery de Gramont; Victor Izrael
[Adenocarcinoma of the pancreas. Diagnosis and evaluation].
Presse médicale (Paris, France : 1983) 1998;27(11):537-8.
1998: Thierry André; Jacques Balosso; Christophe Louvet; Joseph GLIGOROV; patrice callard; Aimery de Gramont; Victor Izrael
[Adenocarcinoma of the pancreas. General characteristics].
Presse médicale (Paris, France : 1983) 1998;27(11):533-6.
1998: Christophe Louvet
[Position of adjuvant and palliative chemotherapy in colonic cancer treatment].
Gastroentérologie clinique et biologique 1998;22(3 Suppl):S255-64.
1997: Eric Raymond; C Buquet-Fagot; S Djelloul; Jan Mester; Esteban Cvitkovic; P Allain; Christophe Louvet; Christian Gespach
Antitumor activity of oxaliplatin in combination with 5-fluorouracil and the thymidylate synthase inhibitor AG337 in human colon, breast and ovarian cancers.
Anti-cancer drugs 1997;8(9):876-85.
1997: Eric Raymond; Aimery de Gramont; Christophe Louvet; Christophe Tournigand; B Demuynck; Karine Beerblock; Elisabeth Carola; Marcel Krulik
Clinical benefit with cisplatin, hydroxyurea and 5-fluorouracil/leucovorin in advanced pancreatic adenocarcinoma.
European journal of cancer (Oxford, England : 1990) 1997;33(4):696-7.
1997: Eric Raymond; Y Drolet; L Marpeau; Christophe Louvet; Jean Cady; C Tessier; S Faivre; P Ouellet; A Lavoie; E Rioux; Aimery de Gramont; Marcel Krulik
Long-term follow-up after adjuvant chemotherapy in completely resected early stage ovarian carcinoma.
European journal of obstetrics, gynecology, and reproductive biology 1997;72(2):181-90.
1997: Karine Beerblock; Y Rinaldi; Thierry André; Christophe Louvet; Eric Raymond; Christophe Tournigand; Elisabeth Carola; R Favre; Aimery de Gramont; Marcel Krulik
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour continuous infusion in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
Cancer 1997;79(6):1100-5.
1997: Christophe Tournigand; Christophe Louvet; Aimery de Gramont; E Lucchi; J F Seitz; F Mal; Eric Raymond; Jean Cady; Elisabeth Carola; Marcel Krulik
Bimonthly high dose leucovorin and 5-fluorouracil 48-hour infusion with interferon-alpha-2a in patients with advanced colorectal carcinoma. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
Cancer 1997;79(6):1094-9.
1997: Aimery de Gramont; J Vignoud; Christophe Tournigand; Christophe Louvet; Thierry André; Charles Varette; Eric Raymond; S Moreau; N Le Bail; Marcel Krulik
Oxaliplatin with high-dose leucovorin and 5-fluorouracil 48-hour continuous infusion in pretreated metastatic colorectal cancer.
European journal of cancer (Oxford, England : 1990) 1997;33(2):214-9.
1997: Aimery de Gramont; Jean-François Bosset; Chantal Milan; Philippe Rougier; Olivier Bouché; Pierre-Luc Etienne; François Morvan; Christophe Louvet; T Guillot; Eric François; Laurent Bedenne
Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with bimonthly high-dose leucovorin and fluorouracil bolus plus continuous infusion for advanced colorectal cancer: a French intergroup study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(2):808-15.
1997: Aimery de Gramont; Alain Pigné; Christophe Louvet; Alain Sezeur; L Marpeau; J C Vaillant; Jean Cady; Charles Varette; B Demuynck; J Y Couturier; B Lagadec; Jacques Milliez; J Barrat; Marcel Krulik
[Early debulking surgery after chemotherapy in advanced cancer of the ovary].
Annales de chirurgie 1997;51(10):1069-76.
1997: Aimery de Gramont; Christophe Tournigand; Christophe Louvet; Thierry André; Jean-Luc Molitor; Eric Raymond; S Moreau; J Vignoud; N Le Bail; Marcel Krulik
[Oxaliplatin, folinic acid and 5-fluorouracil (folfox) in pretreated patients with metastatic advanced cancer. The GERCOD].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1997;18(10):769-75.
1997: Aimery de Gramont; Christophe Louvet; Thierry André; Christophe Tournigand; Eric Raymond; Jean-Luc Molitor; Marcel Krulik
[Modulation of 5-fluorouracil with folinic acid in advanced colorectal cancers. Groupe d'étude et de recherche sur les cancers de l'ovaire et digestifs (GERCOD)].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1997;18 Suppl 4():372s-378s.
1997: Christophe Louvet; Aimery de Gramont
[Role and value of oxaliplatin in metastatic colorectal cancers].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1997;18 Suppl 4():368s-371s.
1997: Christophe Louvet
[Chemotherapy of advanced colorectal cancers].
Annales de chirurgie 1997;51(4):361-7.
1997: Jean-Luc Molitor; J Saint-Louis; Christophe Louvet; A Vachon; L Vincent; R Beaulieu
[Large granular T-cell lymphocytic leukemia disclosed by bilateral uveitis: association with celiac disease].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1997;18(3):237-9.
1996: Aimery de Gramont; Christophe Louvet; Thierry André; Christophe Tournigand; Eric Raymond; Marcel Krulik
[Chemotherapy of colorectal cancers with metastases].
Presse médicale (Paris, France : 1983) 1996;25(35):1678-82.
1996: Christophe Louvet; S Djelloul; Marie-Elisabeth Forgue-Lafitte; Jan Mester; A Zimber; Christian Gespach
Antiproliferative effects of the arotinoid Ro 40-8757 in human gastrointestinal and pancreatic cancer cell lines: combinations with 5-fluorouracil and interferon-alpha.
British journal of cancer 1996;74(3):394-9.
1996: Aimery de Gramont; Christophe Louvet; Marcel Krulik
The French experience with infusional 5-fluorouracil in advanced colorectal cancer.
The Journal of infusional chemotherapy 1996;6(3):133-6.
1996: Aimery de Gramont; Christophe Louvet; M Bennamoun; Charles Varette; B Demuynck; Karine Beerblock; S Moreau; D Soubrane; F Mal; Jean-Didier Grangé; D Zylberait; Marcel Krulik
Dual modulation of 5-fluorouracil with folinic acid and hydroxyurea in metastatic colorectal cancer.
The Journal of infusional chemotherapy 1996;6(2):97-101.
1995: Nicole Véronique Smadja; Christophe Louvet; Françoise Isnard; J L Dutel; Marie-Jose Grange; Charles Varette; Marcel Krulik
Cytogenetic study in multiple myeloma at diagnosis: comparison of two techniques.
British journal of haematology 1995;90(3):619-24.
1995: Jean-Luc Molitor; B Demuynck; Christophe Louvet; Charles Varette; L Marpeau; Aimery de Gramont; S Delfau; D Soubrane; A Pigné; J Barrat
[Locoregional recurrences of breast cancer].
Journal de gynécologie, obstétrique et biologie de la reproduction 1995;24(1):13-8.
1995: Eric Raymond; S Cartier; C Canuel; Christophe Louvet; B Demuynck; M Debray; Charles Varette; S Baux; M Mimoun; Aimery de Gramont
[Extravasation of paclitaxel (Taxol)].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1995;16(2):141-2.
1994: Christophe Louvet; S Empereur; D Fagot; E Forgue-Lafitte; Eric Chastre; A Zimber; Jan Mester; Christian Gespach
The arotinoid Ro 40-8757 has antiproliferative effects in drug-resistant human colon and breast cancer cell lines in vitro.
Cancer letters 1994;85(1):83-6.
1994: F Desroys du Roure; Christophe Louvet; Aimery de Gramont; Charles Varette; B Demuynck; Karine Beerblock; M Kulik
[Detection of ovarian adenocarcinoma in the occasion of cerebrovascular complication associated with consumption coagulopathy].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1994;15(1):48-51.
1994: Christophe Tournigand; Christophe Louvet; Aimery de Gramont; C Canuel; Eric Raymond; Charles Varette; Karine Beerblock; B Demuynck; Marcel Krulik
[Leser-Trelat sign and hypercorticism associated with metastatic adenocarcinoma of unknown origin].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1994;15(12):855-6.
1993: Christophe Louvet; Karine Beerblock; Aimery de Gramont; Charles Varette; B Demuynck; M Bennamoun; Jean Cady; S Delfau; J E Maisani; Marcel Krulik
High-dose folinic acid, 5-fluorouracil bolus and infusion in advanced pancreatic adenocarcinoma: a pilot study.
European journal of cancer (Oxford, England : 1990) 1993;29A(8):1217.
1993: Christophe Louvet; Aimery de Gramont; B Demuynck; Karine Beerblock; Charles Varette; D Soubrane; L Marpeau; A Pigné; T Guillot; Marcel Krulik
Folinic acid, 5-fluorouracil bolus and infusion and mitoxantrone with or without cyclophosphamide in metastatic breast cancer.
European journal of cancer (Oxford, England : 1990) 1993;29A(13):1835-8.
1993: E Navarro-Carola; Aimery de Gramont; Christophe Louvet; Charles Varette; B Demuynck; Karine Beerblock; D Soubrane; Jean-Didier Grangé; Marcel Krulik
[Toxicity of levamisole in adjuvant chemotherapy for colorectal cancer].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1993;14(9):821-4.
1992: Christophe Louvet; Aimery de Gramont; B Demuynck; Charles Varette; Karine Beerblock; M Bennamoun; Marcel Krulik
Bi-weekly 2-day schedule of high-dose folinic acid, 5-fluorouracil bolus and infusion in pretreated advanced epithelial ovarian cancer: a phase II study.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1992;3(8):657-8.
1992: M Thuong; Christophe Louvet; J M Bondeville; Aimery de Gramont; B Demuynck; C Canuel; G Conzalez-Canali; M Jagueux; Marcel Krulik
[Bony involvement of the calcaneum in sarcoidosis. A case report].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1992;13(5):378-80.
1992: Nicole Véronique Smadja; Charles Varette; Christophe Louvet; A Gramont; Marcel Krulik
A case of trisomy 5 in a Philadelphia positive leukemia.
Cancer genetics and cytogenetics 1992;61(2):216-7.
1992: Aimery de Gramont; B Demuynck; Christophe Louvet; G Gonzalez-Canali; Charles Varette; A Pigné; L Marpeau; P Herbulot; B Lagadec; Jean Cady
Survival with intraperitoneal cisplatin in advanced ovarian cancer after second-look laparotomy.
American journal of clinical oncology 1992;15(1):7-11.
1992: Christophe Louvet; Aimery de Gramont; M Bennamoun; B Demuynck; Charles Varette; Jean Cady; S Delfau; Jean-Didier Grangé; Olivier Chazouillères; D Zylberait
High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in metastatic colorectal cancer: a 3-day/3-week schedule. Group d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD)
European journal of cancer (Oxford, England : 1990) 1992;28(2-3):611-2.
1992: Aimery de Gramont; B Demuynck; Charles Varette; Christophe Louvet; A Pigne; L Marpeau; B Lagadec; Jean Cady; J Y Couturier; S Delfau
Sequential cisplatin-doxorubicin, early debulking surgery and intraperitoneal chemotherapy in advanced ovarian cancer. Groupe d'Etude et de Recherche sur les Cancers de l'Ovaire et Digestifs (GERCOD).
European journal of cancer (Oxford, England : 1990) 1992;28(1):53-8.
1991: Christophe Louvet; Aimery de Gramont; B Demuynck; B Nordlinger; J E Maisani; B Lagadec; S Delfau; Charles Varette; G Gonzalez-Canali; Marcel Krulik
High-dose folinic acid, 5-fluorouracil bolus and continuous infusion in poor-prognosis patients with advanced measurable gastric cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1991;2(3):229-30.
1991: Nicole Véronique Smadja; Marcel Krulik; Christophe Louvet; Aimery de Gramont; G Gonzalez-Canali; M Mougeot-Martin
Similar cytogenetic abnormalities in two cases of plasma cell leukemia.
Cancer genetics and cytogenetics 1991;52(1):123-9.
1991: Nicole Véronique Smadja; Aimery de Gramont; G Gonzalez-Canali; Christophe Louvet; E Wattel; Marcel Krulik
Cytogenetic study in a bone marrow metastatic Merkel cell carcinoma.
Cancer genetics and cytogenetics 1991;51(1):85-7.
1991: Aimery de Gramont; L Marpeau; B Demuynck; Christophe Louvet; Charles Varette; G Gonzalez-Canali; A Pigné; P Herbulot; B Lagadec; Jean Cady
[Results of intraperitoneal chemotherapy of ovarian cancer].
Journal de gynécologie, obstétrique et biologie de la reproduction 1991;20(3):387-92.
1991: Christophe Louvet; Aimery de Gramont; B Demuynck; Charles Varette; B Lagadec; Jean Cady; Marcel Krulik
[Cisplatin, adriamycin and mitomycin-C in advanced stomach cancer].
Bulletin du cancer 1991;78(9):839-41.
1991: Christophe Louvet; A Lorange; F Letendre; R Beaulieu; H M Pretty; Y Courchesne; J A Neemeh; M Monte; J Latreille
Acute and delayed emesis after cisplatin-based regimen: description and prevention.
Oncology 1991;48(5):392-6.
1989: Aimery de Gramont; Y Drolet; Charles Varette; Christophe Louvet; G Gonzalez-Canall; Marcel Krulik; Jean Cady; A Pigne; L Marpeau; J Barrat
Survival after second-look laparotomy in advanced ovarian epithelial cancer. Study of 86 patients.
European journal of cancer & clinical oncology 1989;25(3):451-7.
1989: Charles Varette; Aimery de Gramont; Christophe Louvet; G Gonzalez-Canali; Marcel Krulik; Y Drolet; A Pigné; L Marpeau; J Barrat; Denis Gallot
[Prognosis in ovarian cancer as a function of the results of the second-look laparatomy].
Journal de gynécologie, obstétrique et biologie de la reproduction 1989;18(2):222-7.
1988: Aimery de Gramont; Marcel Krulik; Jean Cady; B Lagadec; J E Maisani; J P Loiseau; jean didier grange; G Gonzalez-Canali; B Demuynck; Christophe Louvet
High-dose folinic acid and 5-fluorouracil bolus and continuous infusion in advanced colorectal cancer.
European journal of cancer & clinical oncology 1988;24(9):1499-503.
1988: Aimery de Gramont; Marcel Krulik; G Gonzalez Canali; C Canuel; Christophe Louvet; J Debray
[Chemotherapy in cancer of colon. General review].
La Revue de médecine interne / fondée ... par la Société nationale francaise de médecine interne 1988;9(2):208-16.
1987: Aimery de Gramont; Christophe Louvet; Marcel Krulik; Nicole Véronique Smadja; D Donadio; J P Laporte; P Brissaud; J M Delâge; Y Drolet; E Rioux
Erythrocyte mean corpuscular volume during cytotoxic therapy is a predictive parameter of secondary leukemia in Hodgkin's disease.
Cancer 1987;59(2):301-4.
1986: Aimery de Gramont; Christophe Louvet; Marcel Krulik; Nicole Véronique Smadja; D Donadio; J P Laporte; P Brissaud; M Smith; J M Delâge; Y Drolet
Preleukemic changes in cases of nonlymphocytic leukemia secondary to cytotoxic therapy. Analysis of 105 cases.
Cancer 1986;58(3):630-4.
1986: A De Gramont; P Remes; M Krulik; Nicole Véronique Smadja; Y Drolet; D Donadio; Christophe Louvet; P Brissaud; A Sirinelli; C Dray
Acute leukemia after treatment for ovarian cancer. Report of four cases and review of the literature.
Oncology 1986;43(3):165-72.
1986: Aimery de Gramont; Y Drolet; Christophe Louvet; C Dray; Marcel Krulik; A Pigné; A Lavoie; M Painchaud; R Blouin; C Tessier
[Chemotherapy in 143 advanced epithelial cancers of the ovary. Experience at the Hôtel-Dieu of Quebec and Hôpital Saint-Antoine (Paris)].
Journal de gynécologie, obstétrique et biologie de la reproduction 1986;15(1):105-9.
1985: Christophe Louvet; C Dray; Aimery de Gramont; Nicole Véronique Smadja; P Brissaud; A Sirinelli; Marcel Krulik; J Debray
[Simultaneous detection of bronchopulmonary cancer and acute myeloid leukemia].
Presse médicale (Paris, France : 1983) 1985;14(29):1560.
1985: Christophe Louvet; Aimery de Gramont; M Krulik; M Jagueux; D Hubert; P Brissaud; A Sirinelli; B Augereau; J M Tubiana; J Debray
Extraskeletal mesenchymal chondrosarcoma: case report and review of the literature.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1985;3(6):858-63.